Effect of Rapid Molecular Diagnostic Implementation on Time to Targeted Antibiotic Treatment for Bloodstream Infections: A Before-and-After Study at a Community Teaching Hospital
The Senior Care Pharmacist · 01.08.2026 · 41 (5) · 198-210
DOI: 10.4140/tcp.n.2026.198 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Senior Care Pharmacist, erschienen am 01.08.2026. Verfasst von Brant Botill und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1Cleveland Clinic Martin, Stuart, FL. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteremia, Molecular Diagnostic Techniques. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Purpose
Bloodstream infections (BSIs) require prompt, targeted antimicrobial therapy, but traditional blood culture methods may delay optimal treatment. The BIOFIRE® Blood Culture Identification 2 (BCID2) panel provides rapid pathogen identification and mayreduce time to targeted therapy. This study evaluated the impact of BCID2 implementation at a community teaching hospital.
Methods
A retrospective, quasi-experimental pre/post study was conducted at a for-profit community teaching hospital in adults aged ≥18 years with BSIs. Eligible patients had bacteremia, blood cultures collected, and empiric antibiotic therapy initiated during the study periods. Exclusion criteria included pregnancy, detection of multiple pathogens in a single culture, availability of susceptibility results before the designated timeline, and discharge, transfer, or leaving against medical advice before completion of testing. The pre-implementation group included 64 patients (October-December 2023), and the postimplementation group included 60 patients (October 2024-February 2025). The primary outcome was time from blood culture collection to initiation of targeted antibiotic therapy based on final susceptibility results. Secondary outcomes included pathogen identification, empiric and total antibiotic use, and length of stay.
Results
The study included 124 patients (mean age, 70.5 ± 17.3 years; 67% ≥65 years; 50% male). Blood cultures were ordered for suspected sepsis/septic shock in 58% of patients and suspected secondary bacteremia in 42%. Pathogen distribution was similar between groups, with Escherichia coli , Staphylococcus epidermidis , Enterococcus faecalis , and Staphylococcus aureus identified most frequently. BCID2 implementation significantly reduced time to optimal therapy (3.73 ± 2.01 vs. 2.02 ± 1.48 days, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1Cleveland Clinic Martin, Stuart, FL.
- 2Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy, West Palm Beach, FL.
- 3Wellington Regional Medical Center, Wellington, FL.
Zitieren
APA
Botill, B., Bui, L., Collins, J., Hearing, A., & Guirguis, E. (2026). Effect of Rapid Molecular Diagnostic Implementation on Time to Targeted Antibiotic Treatment for Bloodstream Infections: A Before-and-After Study at a Community Teaching Hospital. The Senior Care Pharmacist, 41(5), 198-210. https://doi.org/10.4140/tcp.n.2026.198
Vancouver
Botill B, Bui L, Collins J, Hearing A, Guirguis E. Effect of Rapid Molecular Diagnostic Implementation on Time to Targeted Antibiotic Treatment for Bloodstream Infections: A Before-and-After Study at a Community Teaching Hospital. The Senior Care Pharmacist. 2026;41(5):198-210. doi:10.4140/tcp.n.2026.198
BibTeX
@article{Botill2026,
author = {Botill, Brant and Bui, Lan and Collins, Jennifer and Hearing, Ariel and Guirguis, Erenie},
title = {Effect of Rapid Molecular Diagnostic Implementation on Time to Targeted Antibiotic Treatment for Bloodstream Infections: A Before-and-After Study at a Community Teaching Hospital},
journal = {The Senior Care Pharmacist},
year = {2026},
volume = {41},
number = {5},
pages = {198--210},
doi = {10.4140/tcp.n.2026.198}
}
EUVIMED